Professor, Hepatologist, and Chief of Clinical Research Affairs
University of South Dakota, Avera University Hospital and Transplant Institute, and Institute of Human Genetics Research
Sioux Falls, SD
Ashwani Singal, MD, MS, FACG, is a Professor of Medicine at the University of South Dakota Sanford School of Medicine and transplant hepatologist at the Avera transplant institute. In addition, he also directs the hepatology elective course for the senior medical students at the Sanford Medical School and is Chief of clinical research affairs at the Avera transplant institute. With clinical and translational research interests in alcoholic and non-alcoholic fatty liver diseases, renal injury in cirrhosis, and porphyria, Dr. Singal’s research has been funded by the ACG, NIH, and pharmaceutical industry. He has over 230 original peer-reviewed articles in national/international journals and book chapters. He is on the editorial board of many journals, including hepatology, liver transplantation, seminars in liver diseases; co-editor in chief for Translational Gastroenterology Hepatology, section editor for hepatology in Frontiers in Gastroenterology and Current Hepatology Reports; and associate editor for digestive liver disease, PLoS one, journal of clinical translational hepatology, and journal of clinical and experimental hepatology. Apart from reviewing research grants and scientific research abstracts for the AGA and AASLD, Dr. Singal is on the study section for the NIH. He is lead author on practice guidelines for alcoholic liver disease, has co-authored guidelines on vascular disorders of the liver, and is currently involved in writing guidelines on nutritional management of patients with cirrhosis and revision of guidelines on alcohol-associated liver disease. Dr. Singal has been awarded the prestigious Edgar Achkar Visiting Professorship by the ACG, and has chaired (2020-2021) the special interest group on alcohol-related liver disease of the AASLD.
Monday, October 24, 2022
ON DEMAND (Must purchase Bonus Sessions to have access)
Monday, October 24, 2022
ON DEMAND (Must purchase Bonus Sessions to have access)
Monday, October 24, 2022
7:00 AM – 7:45 AM ET